$VVCIF $VIVO.V New Medical Cannabis Products, Upcoming Q1 2019 Results

$TGODF $TGOD Analysts Project Incredible Growth for Global Cannabis Industry

May 22, 2019

Palm Beach, FL – May 22, 2019 –  Analysts at Piper Jaffray say we could be looking at a global market value of between $250 billion to $500 billion a year.  “We believe the long-term growth can be significant — both from transitioning illicit trade to legal sales, medical sales, and from transitioning sales in health [and] wellness categories to CBD-infused products.” Some of the top companies in the industry include RavenQuest BioMed Inc. (CSE:RQB)(OTC:RVVQF), OrganiGram Holdings Inc. (TSX-V:OGI) (NASDAQ:OGI), Harvest One Cannabis Inc. (TSX-V:HVT)(OTC:HRVOF), The Green Organic Dutchman Holdings Ltd. (TSX:TGOD)(OTC:TGODF), and The Supreme Cannabis Company Inc. (TSX:FIRE)(OTC:SPRWF).

RavenQuest BioMed Inc. (CSE:RQB)(OTCQB:RVVQF) BREAKING NEWS: RavenQuest BioMed Inc. just announced that it signed a Heads of Agreement with Norway’s s Cannabis BioCare A/ to enter into a joint venture to construct cannabis production facilities using RavenQuest’s Orbital Garden grow technology in certain geographic regions. It is anticipated that production facilities will be constructed within twenty-four months, with the capacity to produce up to 35,000 kilograms of cannabis annually.

“Our organization has quietly and patiently conducted research as a pre-cursor to entry into the global cannabis marketplace. Our due diligence process has been exhaustive and has involved conversations with several Canadian cannabis companies including five companies with market capitalizations in the billions of dollars. Ultimately, we chose to partner with one of the most scientific, innovative and fundamentally sound cannabis projects worldwide, namely RavenQuest BioMed,” said Cannabis Biocare founder, Gerhard Ludvigsen.  Read more news for RQB at https://rqbglobal.com/category/news/

Other cannabis-related developments from around the markets include:

OrganiGram Holdings Inc. (TSX-V: OGI.V) (NASDAQ:OGI) just announced that it applied to list its common shares on the NASDAQ Global Select Market.  In advance of anticipated listing on the NASDAQ, Organigram will file a Form 40-F Registration Statement with the United States Securities and Exchange Commission.  The listing of the Company’s common shares on the NASDAQ remains subject to the approval of the NASDAQ and the satisfaction of all applicable listing and regulatory requirements.  The Company will continue to maintain the listing of its common shares on the TSX Venture Exchange under the symbol “OGI”.

“As a management team we are seeing increased interest from investors in the U.S. and internationally and believe that having a listing on the NASDAQ will facilitate trading” says Paolo De Luca, Chief Financial Officer of Organigram. “In addition, based on precedents in the cannabis space, we expect trading volumes to increase which should result in increased liquidity for all investors”.

Harvest One Cannabis Inc. (TSX-V:HVT)(OTCQX:HRVOF) just acquired 52% interest in Greenbelt Greenhouse Ltd. an Ontario private company located in Hamilton, Ontario.  This strategic acquisition will supply Harvest One with high quality greenhouse grown cannabis from Greenbelt’s 152,000 sq. ft. facility which will primarily be dedicated to Harvest One’s expanding cannabis-infused health, wellness, and self-care products under the Dream Water and Satipharm brands, and expanding products resulting from the recently announced acquisition of Delivra, following the closing of that transaction. The Transaction ensures that Harvest One remains a vertically integrated house of brands by controlling the production of cannabis through cultivation and extraction, and ultimately to packaged good for consumers.

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD)(OTCQX:TGODF) just announced that it has obtained approval from Health Canada, under the Cannabis Regulations, to expand operations into its new building located in Hamilton, Ontario. The 20,000 square feet indoor facility is going to be used for cannabis cultivation; planting will start in the coming weeks.  “This is yet another important milestone for our team as we continue to ramp up production with a focus on executional excellence,” commented Brian Athaide, CEO of TGOD. “We have pioneered the concept of sustainably growing all-natural, certified organic cannabis at scale. The product we are able to offer Canadians is clean, pesticide-free and undeniably premium.”

The Supreme Cannabis Company Inc. (TSX: FIRE)(OTCQX: SPRWF) just announced that its wholly-owned subsidiary, 7ACRES obtained Health Canada approval for five additional flowering rooms totaling 50,000 sq ft of additional production space at its facility in Kincardine, Ontario. Total flowering room space at 7ACRES increases from 180,000 sq ft to 230,000 sq ft and 7ACRES’ annual production capacity estimate increases from approximately 26,250kg to 33,580kg. As noted previously, Supreme Cannabis expects to realize further production efficiencies following the licensing of all 25 flowering rooms, whereby 7ACRES’ potential capacity is anticipated to reach approximately 50,000kg.  “With five more flowering rooms at 7ACRES now approved by Health Canada, the finish line is in sight,” said John Fowler, President and Founder of Supreme Cannabis.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third- party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM expects to be compensated twenty-five hundred dollars for news coverage of the current press release issued by RavenQuest BioMed Inc. by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$LXRP and Nuka Enterprises’ 1906 Expand Cannabis Product Relationship

1906 fast-acting edibles products, powered by Lexaria’s DehydraTECH technology, will expand across the US in 2019 and 2020

Kelowna, British Columbia May 21, 2019 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX), an innovator in drug delivery platforms, today announced the most reliable fast acting edibles on the market will now be available across the country through a major expansion in operations by Nuka Enterprises LLC, (“Nuka”) maker of 1906 cannabis edibles for high functioning adults.

Last year, Nuka acquired contractual options to expand its use of DehydraTECHTM technology. Exercising some of those options, Nuka plans to expand operations for cannabis chocolates and edibles in six additional states and cannabis beverages in three states in 2019 and 2020.

“As the fastest growing edibles brand in Colorado, we believe a huge part of our consumer appeal is because of this fast-acting technology,” said Peter Barsoom, Nuka Enterprises CEO and Co-Founder. “We look forward to continuing to innovate alongside Lexaria, whose technology is the best in the industry.”

Currently, 1906 offers six distinct formulations that combine low-dose cannabis with targeted plant medicines. Over the next two years, 1906 is expanding their product offerings to other legal markets including: Illinois, Ohio, Massachusetts, Michigan and others. Overall, roughly a ten-fold increase in product volumes manufactured by Nuka utilizing DehydraTECH is expected over the next eighteen months.

As part of its mission to bring cannabis back to its pre-prohibition status as a mainstream, widely used medicine for the greater good, Nuka will also begin using DehydraTECH to create consumer products containing CBD. Lexaria recently announced that its technology was able to deliver 475% more CBD after just 15 minutes than conventional industry formulations.

Nuka has utilized Lexaria’s technology within its award-winning 1906 chocolates for roughly three years. Since its founding in 2016, 1906 has advanced from a start-up to Colorado’s fastest growing edibles company, now available in more than 200 dispensaries. Praise for 1906 products can be seen in Vogue, Penthouse, Cosmo, Eater, The Huffington Post, VICE and many more nationally-recognized publications.

The comprehensive semi-exclusive agreement provides Nuka and 1906 with competitive technological advantages until 2028, as well as growing revenue streams for Lexaria. A second license provides Nuka and 1906 with the immediate ability to utilize DehydraTECH technology for CBD across the US marketplace.

“Nuka’s astonishing growth since launch is impressive and we can’t wait to see what innovative products they design next using DehydraTECH technology,” said Chris Bunka, Chief Executive Officer of Lexaria Bioscience Corp. “Together, we have a market advantage that will significantly change public perception of how and when to consume cannabis and plant medicine because consumers don’t have to wait an hour or longer for their edibles to kick in with 1906 brand.”

On April 30, 2018, Lexaria announced that Nuka had also acquired an option to expand its products and brand to Canada and across the US and that Nuka and 1906 planned to leverage the competitive advantages of DehydraTECH across multiple product lines. They also strategically acquired new rights in product categories in addition to the original chocolate formats, which include candies, beverages, capsules and pills, and topical creams. In doing so, Nuka and 1906 have the opportunity to create America’s first national DehydraTECH-powered cannabis brand for edible and topical products that offer the superior experiential profiles 1906 consumers desire, together with the exceptional flavor and speed of onset benefits.

About Nuka Enterprises and 1906

Nuka Enterprises develops processes, IP and services focused on disrupting the nascent and fast-emerging cannabis industry. Nuka’s 1906 brand is creating a new category of premium edibles that marry the benefits of cannabis and plant medicines, designed to appeal to responsible, informed, health conscious adults. 1906 products deliver distinct highs with functional benefits in fast-acting edible of artisanal chocolate and other high quality ingredients. 1906’s product lineup delivers six unique experiences that promote sleep, energy, arousal, relaxation, cognitive focus, and a happy mood, all in a safe and predictable formulation. For more information, please visit 1906newhighs.com.

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECHTM delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.

www.lexariabioscience.com

For regular updates, connect with Lexaria on Twitter (https://twitter.com/lexariacorp)

and on Facebook https://www.facebook.com/lexariabioscience

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.

Alex Blanchard, Communications Manager

(778) 796-1897

Or

NetworkNewsWire (NNW)

www.NetworkNewsWire.com

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional patent protection will be realized or that patent achievements will deliver material results. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance the Company will be capable of developing, marketing, licensing, or selling edible products containing cannabinoids, nicotine or any other active ingredient. There is no assurance that Nuka Enterprises or any customer, client or licensee will execute their business plans or expansion plans as communicated. There is no assurance that any planned corporate activity, scientific research or study, business venture, letter of intent, technology licensing pursuit, patent application or allowance, consumer study, or any initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

$GNPX to Present at Sachs 5th Annual Forum – NetworkNewsBreaks

$TCAN Executes LOI to Acquire Premier Indoor Cultivator Business and Assets

$NUGS 420 with CNW – California Regulating Marijuana At Local Authority Level

$RIV $RIV.V $CNPOF Portfolio Company Agripharm Awarded Outdoor Cultivation Licence

TORONTO, May 21, 2019 – Canopy Rivers Inc. (“Canopy Rivers” or the “Company”) (TSXV: RIV) (OTC: CNPOF) is pleased to share that its portfolio company, Agripharm Corp. (“Agripharm“), has received its outdoor cultivation license from Health Canada. Agripharm will be growing its first outdoor crop this summer at its Creemore, Ontario location using award-winning genetics.

“We are pleased to see Agripharm diversify its operations and increase its growing capacity with the grant of this outdoor cultivation licence,” said Oliver Dufourmantelle, Chief Operating Officer of Canopy Rivers. “Agripharm’s outdoor production is ahead of the curve with support from Green House Brands, which provides decades of experience in choosing, and successfully growing, the best genetics for open-air crops.”

Founded in 2013, Agripharm is home to both the first cannabis production facility built from the ground up and the first supercritical CO₂ extraction lab in Canada. Agripharm is located in Creemore, Ontario, and operates out of an indoor facility that has been licensed for cannabis production since 2014. Agripharm is co-owned by SLANG Worldwide Inc. (“SLANG Worldwide“) (CNSX: SLNG), Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and Green House Holdings North America Inc. and received a strategic investment from Canopy Rivers. Agripharm has the exclusive Canadian rights to the intellectual property, strains and brands of Green House Seed Co., the preeminent global provider of cannabis genetics, and its sister brand Strain Hunters. Agripharm is also the Canadian distributor of SLANG Worldwide’s portfolio of leading U.S. consumer cannabis brands including, O.penVAPE, Bakked, District Edibles, and Magic Buzz.

“With access to strains optimized for outdoor production from the world’s leading genetics portfolio, Agripharm is well-positioned to significantly increase its production capacity for extraction,” continued Dufourmantelle. “Agripharm has robust internal extraction capabilities primed to bring SLANG Worldwide’s most popular U.S. consumer brands to the Canadian cannabis market.”

As a strategic partner of Agripharm, Canopy Rivers provided the capital to finance the build-out of Agripharm’s growing facilities in exchange for a long-term royalty interest subject to annual cash flow minimums. Canopy Rivers made its strategic investment in Agripharm in 2017, recognizing the strength of its extraction capabilities and its unique partnerships with Green House Seed Co. and SLANG Worldwide. For more information regarding the Company’s investment in Agripharm, please refer to the joint management information circular of Canopy Rivers Corporation and the Company dated August 8, 2018, filed with Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com.

About Canopy Rivers:

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.

Forward-Looking Statements

This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Canopy Rivers with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding: Agripharm’s plan to grow its first outdoor crop; the impact of the outdoor cultivation license on Agripharm’s operations and growing capacity; Agripharm’s production capacity; Agripharm’s extraction capabilities, partnerships and licensed genetics and brands; Agripharm’s ability to bring SLANG Worldwide’s popular U.S. consumer brands to Canada; and other expectations regarding economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Canopy Rivers believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of Canopy Rivers. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; Agripharm’s ability to grow its first outdoor crop; the actual impact of the outdoor cultivation license on Agripharm’s operations and growing capacity; Agripharm’s ability to increase its production capacity for extraction and collaborate with its partners; the success of Agripharm’s licensed genetics and brands; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in Canopy Rivers’ final short form prospectus dated February 21, 2019, filed with Canadian securities regulators and available on Canopy Rivers’ profile on SEDAR at www.sedar.com.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Canopy Rivers has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Canopy Rivers does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

$VVCIF 420 with CNW – New Jersey Unveils Changes to Medical Marijuana Rules

$TCAN Executes LOI To Acquire Business, Assets of Premier Indoor Cultivator

TransCanna Holdings Inc. (CSE:TCAN: XETR: TH8) (“TransCanna” or the “Company”) is pleased to announce the execution of a non-binding Letter Of Intent dated May 17, 2019 (the “LOI”) with Lyfted Farms, Inc. (“Lyfted”), of Modesto, California, to acquire the business and assets of Lyfted (the “Proposed Acquisition”). Lyfted Farms is a state licensed producer of high quality indoor grown cannabis.  The three permanent state licenses that Lyfted owns are for cultivation (nursery), cultivation (grow), and distribution.

“The Proposed Acquisition includes an exceptional brand, with a range of  high-end flower, growing revenues, fifty exotic and unique genetic strains and a team that’s been a staple in the Modesto valley with over two decades of cultivating experience. In short, this is another example of an ideal acquisition candidate for TransCanna that offers SKU velocity, growing revenues and branded products that differentiate from others in the marketplace,” stated Jim Pakulis, CEO of TransCanna.

“Being a premier cultivator, we thrive on new, cutting edge processes to generate superior results. We’re extremely excited about joining forces with the team at TransCanna,” stated Bob Blink, President of Lyfted Farms.

“The acquisition by TransCanna would allow us to solve our biggest current challenge, which is the limited cultivation space at our indoor facilities.  We’re already the number one selling vendor of products among the top seven dispensaries locally. It’s now time for us to scale throughout the state. TranCanna’s impressive facility in Modesto, not far from our present location, and their vertically integrated strategy, including distribution, will enable us to achieve that.”

On closing of the Proposed Acquisition, Lyfted will receive total consideration of US$5.5 million in cash and one million shares. The Company will pay US$2.75 million at closing and issue a 12 month, unsecured, interest only note for $2.75 million at 7% interest p.a. (the ”Note”). The Note is repayable by the Company in part or in full anytime during its 12 month term. The Company is paying a non-refundable deposit of US$50,000 in cash, which is deductible from the total consideration payable under the terms of the Proposed Acquisition.

The Proposed Acquisition is subject to completion of due diligence, execution of a definitive asset purchase agreement, which is to be completed within 45 days of the date of the LOI, and relevant regulatory approvals. There can be no assurances that the completion of the Proposed Acquisition will occur on the terms set forth above or at all.

For further information, please visit the Company’s website at www.transcanna.com.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.

Media Contact
TransCanna@talkshopmedia.com
604-738-2220

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer

Telephone: (604) 609-6199

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to:  the expected purchase of Lyfted, the terms of the Asset acquisition,, the ability of the Company to secure financing and the acquisition of appropriate licenses. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

$OGRMF $OGI to Invest $15 Million in Industry-Leading Infused Chocolate Innovation

Company positioning itself to compete within the expected largest cannabis edibles segment

MONCTON, NB, May 20, 2019 – Anticipating the legalization of adult-use cannabis edibles, and ready to demonstrate a leadership position in the edibles market, Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQX:OGRMF), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce a $15 million investment commitment in a high-speed, high-capacity, fully-automated production line with ability to produce an estimated 4 million kilograms of exceptional chocolate cannabis edibles per year. Organigram expects to take delivery of the line in the fall.

In addition to its sheer capacity, adaptability to the anticipated future growth of the domestic and international chocolate edibles markets, the line is expected to allow Organigram’s product development team to introduce chocolate innovations unique not only to the cannabis industry but to the chocolate industry as a whole.

“Over the last number of years, Organigram has become known for its best-in-class cannabis production facility and high-quality products,” says Greg Engel, CEO, Organigram. “With this investment, we will soon also be known for our world-class chocolate production capability.”

The full Organigram chocolate offering that is under development is expected to be supported by a carefully curated collection of partners and suppliers identified for their own global expertise and unwavering commitment to quality. The investment will contribute to a state-of-the-art chocolate molding line and a fully integrated packaging line, that includes advanced engineering, robotics, high-speed labeling, and automated shipping carton packing.

Organigram’s plan for chocolate production reflects the Company’s commitment to transformative thinking leading to innovative product development.

“We continually look for opportunities to lead,” says Engel. “That leadership begins with creativity and curiosity and ends when we have a portfolio of novel products that delight our customers.”

Chocolate Expertise

Organigram’s foray into chocolate is led by a product development and production team with more than 25 years of combined chocolate experience and expertise.

As previous Vice President, Operations at Ganong Bros Limited, Jeff Purcell, Organigram’s Senior Vice President of Operations, will leverage his many years of chocolate experience to implement and manage the project. The Company has also recruited a marketing, product development and a research team led by Ginette Ahier, previously of Adorable Chocolate, and Mouna Gharsallah, previously of Tunisia based Sotuchoc.

“Not only have we invested in exceptional technology, but we have also brought an outstanding team to the table,” says Engel. “I don’t believe there is another team assembled out there that can rival ours when it comes to understanding – and reimagining – the potential of chocolate cannabis-infused edibles.”

Investor Relations Services

As previously announced, the Company will commence trading on the NASDAQ Global Select Market on May 21, 2019. To coincide with this new listing, Organigram has engaged Native Ads, Inc. (“Native Ads”) to provide and manage a digital media marketing campaign for the Company. The Company has entered into a master services agreement with Native Ads for a total cost of approximately CAD$270,000 and neither Native Ads nor any of its directors and officers own any securities of the Company. The agreement has an initial term of 6 months. Native Ads will provide content development, web development, media distribution, and campaign reporting and optimization.

Native Ads with a registered office at 244 Fifth Avenue, New York, New York, is in the business of providing strategic digital media services, marketing and data analytics services. Native Ads owns and operates a proprietary ad exchange with over 80 integrated SSPs (supply-side platforms) resulting in access to 3-7 billion daily North American ad impressions. The full-service ad agency arm leverages its proprietary platform and traffic buying methodologies to assist issuer clients with high volume content dissemination to appropriate audiences at the appropriate times.

Organigram is also pleased to announce that it has entered into an agreement with Hybrid Financial Ltd. (“Hybrid”) to provide Organigram marketing services to advisors, brokers and institutional investors in North America. Under the terms of the agreement, Organigram will pay a monthly retainer of approximately CAD$51,000. The agreement is month to month and may be terminated by Organigram on 15 days notice.

Hybrid is a sales and distribution company that actively connects issuers to the investment community. With offices in both Toronto and Montreal, Hybrid offers comprehensive coverage of both the Canadian and U.S. markets. Neither Hybrid nor any of its directors and officers own any securities of Organigram.

About Organigram Holdings Inc.

Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQX:OGRMF)is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds, and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such statements include statements with respect to the growth of the edibles market, Organigram’s expected market position, size of the chocolate segment as part of the overall edibles market, the timing for delivery. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks associated with new product categories, regulation and timing for implementation, and such risks as disclosed in the Company’s most recent annual information form and other Company’s documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. We seek safe harbor.

$GGBXF Announces Acquisition of Second Nevada Cultivation Facility

$TGOD $TGODF Retail Cannabis Likely to Be the Next Investment Boom

Palm Beach, FL – May 17, 2019 – After years of prohibition, cannabis is taking center stage as legalization rolls across the U.S. and most of the global community.  In fact, according to New Frontier Data there are about 272 million cannabis consumers globally, or 4% of the global population.  Also, these consumers have spent upwards of $356 billion each year on cannabis.

“Cannabis legalization and decriminalization has not only occurred in nearly 60% of the United States; it is now being explored or adopted in over 60 nations around the world. Our data shows full federal legalization, specifically in the U.S., will drive material gains across key economic sectors, including federal revenue generation, national job creation, and reduced government healthcare spending and crime rates,” said Giadha Aguirre de Carcer, Founder and CEO of New Frontier Data. That’s great news for the cannabis retail industry.  Some of the top companies in the industry include High Tide Inc. (CSE:HITI)(OTC:HITIF), Fire & Flower Holdings Corporation (TSX-V:FAF)(OTC:FFLWF), OrganiGram Holdings Inc. (TSX-V:OGI) (OTC:OGRMF), Harvest One Cannabis Inc. (TSX-V:HVT)(OTC:HRVOF), and Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF).

High Tide Inc. (CSE:HITI)(OTCQB:HITIF) BREAKING NEWS:  High Tide Inc. just announced that Canna Cabana has been granted membership into the Canadian Franchise Association (“CFA”). High Tide is now in possession of a Certificate of Membership for both the Smoker’s Corner retail smoking accessories business and the Canna Cabana retail cannabis business, which is unique in Canada.

“With Canna Cabana becoming a CFA member, we can now offer potential franchisees the unparalleled choice between two CFA-approved cannabis-related businesses to purchase and operate,” said Raj Grover, President and Chief Executive Officer of High Tide. “With a total of nine current franchisees between the Smoker’s Corner and Canna Cabana businesses, franchising has been an integral part of High Tide’s retail strategy since 2014.”

According to the CFA, Canadian franchises contribute over $100 Billion per year to the economy, create jobs for over 1.9 Million Canadians and enable over 76,000 hardworking franchisees to be their own boss as the owner of their own small business.

Other cannabis-related developments from around the markets include:

Fire & Flower Holdings Corporation (TSX-V:FAF)(OTCPK:FFLWF) just announced that it entered into an agreement pursuant to which Fire & Flower will acquire certain assets of vendor, Prairie Sky Cannabis Inc. The Vendor currently operates four licensed retail cannabis shops in the province of Saskatchewan in the communities of Battleford, Estevan, Martensville and Moosomin, Saskatchewan under the name Jimmy’s Cannabis Shop.

“The acquisition of four additional retail cannabis stores in the province of Saskatchewan is the first in Fire & Flower’s aggressive acquisition strategy for 2019. In conjunction with our Open Fields wholesale distribution platform in the province, it cements our leadership position in this strategic market. Along with our existing portfolio of organic growth opportunities, the acquisition puts us in a good position to meet our growth goals for the year,” said Trevor Fencott, CEO of Fire & Flower.

OrganiGram Holdings Inc. (TSX-V: OGI.V)(OTCQX:OGRMF) just announced that it applied to list its common shares on the NASDAQ Global Select Market.  In advance of anticipated listing on the NASDAQ, Organigram will file a Form 40-F Registration Statement with the United States Securities and Exchange Commission.  The listing of the Company’s common shares on the NASDAQ remains subject to the approval of the NASDAQ and the satisfaction of all applicable listing and regulatory requirements.  The Company will continue to maintain the listing of its common shares on the TSX Venture Exchange under the symbol “OGI”.

“As a management team we are seeing increased interest from investors in the U.S. and internationally and believe that having a listing on the NASDAQ will facilitate trading” says Paolo De Luca, Chief Financial Officer of Organigram. “In addition, based on precedents in the cannabis space, we expect trading volumes to increase which should result in increased liquidity for all investors”.

Harvest One Cannabis Inc. (TSX-V:HVT)(OTCQX:HRVOF) just acquired 52% interest in Greenbelt Greenhouse Ltd. an Ontario private company located in Hamilton, Ontario.  This strategic acquisition will supply Harvest One with high quality greenhouse grown cannabis from Greenbelt’s 152,000 sq. ft. facility which will primarily be dedicated to Harvest One’s expanding cannabis-infused health, wellness, and self-care products under the Dream Water and Satipharm brands, and expanding products resulting from the recently announced acquisition of Delivra, following the closing of that transaction. The Transaction ensures that Harvest One remains a vertically integrated house of brands by controlling the production of cannabis through cultivation and extraction, and ultimately to packaged good for consumers.

The Green Organic Dutchman (TSX:TGOD) (OTCQX:TGODF) is developing a distribution hub for beverage and edible products for Canada and abroad.  “We believe that the beverage and edible market will be the largest single segment of the cannabis market. Cannabis, as the base ingredient, makes these products possible. The medicinal and recreational market for CBD and THC will only increase over time and starting with an organic input is the most important aspect to developing these higher margin products,” notes TGOD President Csaba Reider.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third- party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM expects to be compensated twenty-five hundred dollars for news coverage of the current press release issued by High Tide Inc. by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$GNPX Taking Unique Gene Therapy Approach to Cancer Treatment

$NETE Aptito to Showcase New Android Based POS @ 2019 NRAS

Aptito introduces its new Android-based POS software powered by HP hardware, Poynt and Pax Smart Terminals

MIAMI, FL, May 17, 2019 — via NEWMEDIAWIRE — Net Element, Inc. (NASDAQ: NETE) (“Net Element” or the “Company”), a global technology and value-added solutions group that supports electronic payments acceptance in a multichannel environment including point-of-sale (POS), e-commerce and mobile devices, today announces that its Aptito subsidiary’s retail and restaurant solutions will be showcased at the 2019 National Restaurant Association Show taking place May 18-21, at the McCormick Place in Chicago, Illinois.

The National Restaurant Association Show is the nation’s most recognized restaurant industry-focused event to exploring the most current happenings in the restaurant industry and showcasing the latest equipment and supplies for the food and beverage sector.  More than 43,000 foodservice buyers and 2,400 exhibitors are expected to attend the event. Aptito is releasing its Aptito One and Aptito One Tab at the show.  These payment solutions streamline payment and order acceptance into one device and facilitate ordering and paying at the table via Apple Pay and Google Pay as well as by credit and debit cards.

Aptito’s presentation at the National Restaurant Association Show will showcase its robust restaurant solutions with an emphasis on its all-new Android architecture POS software, which is powered by HP hardware, Poynt, PAX smart terminals and completely new server-side infrastructure allowing seamless communication between local and cloud servers and advanced APIs.  With the new addition of Android as a platform, Aptito aims to expand its market share by offering two of the most widely used POS platforms in the industry to restaurants.

During the event Aptito will host a contest to give away one HP Smart Terminal with a three-year Aptito software license.  The winner will be able to process transactions faster, keep their customers engaged and leverage the powerful features of this state-of-the-art smart point-of-sale solution to better manage their business and improve their bottom line.

APTITO ONE BENEFITS:

•  Equipment built specifically for your restaurant or retail business
•  New up-to-date software custom built for Android
•  Fully integrated hardware with the POS software
•  Wide range of cost-effective solutions
•  Easier to scale as a business grows
•  Bigger screens for a better user experience

“Aptito restaurant solutions make restaurants stand out from the competition with interactive menus, self-ordering kiosks and seamless back-office integration,” commented Andrey Krotov, chief technology officer of Net Element. “We’ll be showcasing our new pay-at-the-table solution, Aptito One Tab, so stop by Aptito’s booth No. 8321 at the National Restaurant Association Show so attendees can discover, learn and join the Aptito revolution!”

About Aptito
Aptito’s Point-of-Sale (POS) solution has become an industry leader thanks to our easy-to-use system, digital menu software and diverse bar & restaurant management tools that empower merchants to grow and optimize their business, decrease expenses and streamline operations while delivering a better customer experience through quick and convenient checkout options.  Aptito’s kiosks and mobile Point-of-Sale (mPOS) solutions are cloud-based, offering its owners remote access so they can always feel the pulse of their operation, regardless of physical location. Further information is available at www.aptito.com.

About Net Element
Net Element, Inc. (NASDAQ: NETE) operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the U.S. and selected emerging markets. In the U.S. it aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, our cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omnichannel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500™.  In 2017, Net Element  was recognized by South Florida Business Journal as one of 2016’s fastest growing technology companies. Further information is available at www.NetElement.com.

Forward-Looking Statements
Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Net Element and are difficult to predict. Examples of such risks and uncertainties include to whether Aptito’s restaurant solutions will yield any benefits to the Company. Additional  examples of such risks and uncertainties include, but are not limited to: (i) Net Element’s ability (or inability) to obtain additional financing in sufficient amounts or on acceptable terms when needed; (ii) Net Element’s ability to maintain existing, and secure additional, contracts with users of its payment processing services; (iii) Net Element’s ability to successfully expand in existing markets and enter new markets; (iv) Net Element’s ability to successfully manage and integrate any acquisitions of businesses, solutions or technologies; (v) unanticipated operating costs, transaction costs and actual or contingent liabilities; (vi) the ability to attract and retain qualified employees and key personnel; (vii) adverse effects of increased competition on Net Element’s business; (viii) changes in government licensing and regulation that may adversely affect Net Element’s business; (ix) the risk that changes in consumer behavior could adversely affect Net Element’s business; (x) Net Element’s ability to protect its intellectual property; (xi) local, industry and general business and economic conditions; (xii) adverse effects of potentially deteriorating U.S.-Russia relations, including, without limitation, over a conflict related to Ukraine, including a risk of further U.S. government sanctions or other legal restrictions on U.S. businesses doing business in Russia. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K filed by Net Elementwith the Securities and Exchange Commission. Net Element anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Net Element assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

Contact:
Net Element, Inc.
+1 (786) 923-0502
www.netelement.com
Media@NetElement.com

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
+1 (212) 418-1217
www.NetworkNewsWire.com
Editor@NetworkNewsWire.com

$OGRMF Announces May 21st Inaugural Date of Trading on Nasdaq

MONCTON, May 17, 2019 – Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that its common shares will commence trading on the Nasdaq Global Select Market under the symbol “OGI” on Tuesday May 21, 2019. Organigram’s common shares will continue to be listed and trade on the Toronto Venture Exchange (TSXV), also under the symbol “OGI”. The Company’s common shares will continue to trade on the OTCQX under the symbol “OGRMF” until market close on May 20, 2019.

In conjunction with this Nasdaq listing, Organigram’s common shares will become DWAC/FAST eligible for U.S. shareholders.

“We are pleased to celebrate this significant company milestone,” says Greg Engel, CEO, Organigram. “We are proud to have assembled a world-class team and facility that continues to deliver value to our shareholders. This listing will help us continue to demonstrate our commitment to dynamic growth.”

About Organigram Holdings Inc. 

Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada.

Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such statements include statements with respect to its inaugural trading date. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks associated with timing and regulatory approvals and such risks as disclosed in the Company’s most recent annual information form and other Company’s documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. We seek safe harbor.

$PBIO Host Teleconference to Discuss Q1 2019 Financial Results and Provide Business Update

$NETE Reports Q1 2019 Financial Results, Provides Business Update

$TCAN Enters LOI to Acquire SolDaze Cannabis Snack Line

$LXRP Responds to High Demand for Cannabis-Infused Beverages

• The company aims to promote healthier administration methods, eliminating the need for sweeteners to mask taste
• Lexaria’s mission is to save lives with its technology, which allows for delivery of drug molecules through ingestible means
• The company is seeing high demand in North American markets for DehydraTECH in cannabis-infused beverages
• Lexaria recently announced its entry into a CBD-beverage formulation license agreement with a Nevada-based company

Traditionally, consumers have relied on smoking to achieve higher absorption rates and fast onset of bioactive compounds such as nicotine and cannabinoids. Ingesting drugs and molecules through edibles is simply safer than inhaling them. However, the absorption of edibles has proven slow, and the taste can be unpleasant without the aid of sweeteners.

Now, thanks to a revolutionary oral technology, it is possible to deliver bioactive substances via oral ingestion without the need for the unhealthy practices of inhalational or added…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://nnw.fm/LXRP

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$GGBXF Completes 27.3 Million Share Buyback and Cancels 13% of Outstanding Shares

COLUMBUS, May 16, 2019 – Green Growth Brands, Inc. (CSE: GGB) (OTCQB: GGBXF) (“GGB” or the “Company”) is pleased to announce that it has completed the repurchase (the “Repurchase Transaction”) and cancellation of 27,300,000 of its common shares held by GA Opportunities Corp. (“GAOC”) (previously announced on April 15, 2019), representing approximately 13% of its outstanding shares. Aggregate consideration for the Repurchase Transaction was C$89 million, or approximately C$3.26 per common share, at a significant discount to the current market price of GGB’s common shares.

‘We are pleased to have completed our buy back of the shares previously held by GA Opportunities,” said Peter Horvath, CEO of GGB.  “While we continue to focus on the rapid expansion of GGB, the opportunity to repurchase these shares well below the current market price immediately and directly increased shareholder value.”

The aggregate consideration for the Repurchase Transaction was satisfied by delivery of a secured promissory note (the “Note”) in the principal amount of C$39,000,000 and cash in the amount of C$50,000,000. The cash portion of the consideration was satisfied by the proceeds received by the Company from the sale of common shares of Aphria Inc. and the exercise of Company common share and proportionate voting share warrants, with the balance satisfied by cash on hand.  As previously disclosed, the Note is payable in six months from the closing of the Repurchase Transaction and bears interest at 3% per annum.

About Green Growth Brands Inc.
Green Growth Brands creates remarkable experiences in cannabis and CBD, led by CEO Peter Horvath and a leadership team of consumer-focused retail experts. Their brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily and Meri + Jayne, with a licensing agreement with the Greg Norman Brand. Already boasting the strongest sales per square feet in the cannabis industry, GGB is expanding its presence in Nevada, Massachusetts and Arizona with CBD presence at ShopSeventhSense.com, in malls across the country and at DSW shoe stores—and that’s just the beginning. Learn more about our vision at GreenGrowthBrands.com.

Cautionary Statements:
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company’s current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to, among other things, repayment of the Note. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the Company. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such events will occur or will be completed on the terms described above.

The forward-looking information contained in this release is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any securities and neither this announcement nor anything contained in it shall form the basis of any contract or commitment.  In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or in any other jurisdiction in which such an offer would be illegal. The securities referred to herein have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, within the United States, unless the securities have been registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

$TGOD $TGODF U.S. To Remain atop Global Cannabis Market Share

Palm Beach, FL – May 16, 2019 – Reports show and predict that the U.S. will be at the epicenter of the global cannabis/marijuana markets. A report called “The State of Legal Marijuana Markets, 6th Edition”, from Arcview Market Research and BDS Analytics report states, “Legal adult-use sales will largely be a North American phenomenon,” and today the U.S. reigns in the legal cannabis market worldwide... By 2022, legal cannabis revenue in the U.S. market is projected to hit $23.4 billion (73% of the market). During the same period, Canada is projected to reach $5.5 billion (17%) and at $3.1 billion, the rest of the world will represent almost 10% of the legal cannabis market.”   Another article by an industry website looking at the global market said: “If more countries fully legalize cannabis, including the United States and all European countries, the global cannabis market could be worth $194 billion in seven years according to a new report from the Bank of Montreal. It could lead to a $30 billion medical cannabis market and a $68 billion recreational market in Europe. In the U.S., legalization would mean up to $19 billion medical cannabis sales and a further $49 billion from the adult-use of cannabis.  Active Companies from around the market with current developments this week include:  Leafbuyer Technologies, Inc. (OTC: LBUY), The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTC: TGODF), Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), CV Sciences, Inc. (OTC: CVSI), Canopy Growth Corporation (NYSE: CGC) (TSX: WEED).

Reports are indicating the global legal cannabis market amounted to $9.5 billion in 2017, growing by 37 percent on the year. The North America legal cannabis market reached $12 billion in 2018, growing by 30 percent on the year. The largest market was the United States, which totaled $10.4 billion. It was followed by Canada with $1.6 billion.  Analysts predicts the overall cannabis market for legal adult-use and medical sales in North America to reach $24.5 billion by 2021 and will grow to $47.3 billion six years later. That brings the compound annual growth rate (CAGR) to almost 28%, however the largest growth rate is predicted within the rest-of-world markets, from $52 million spent in 2017 to a projected $2.5 billion in 2027.

Leafbuyer Technologies, Inc. (OTCQB: LBUY) BREAKING NEWS:  Leafbuyer Technologies, a leading cannabis marketing and technology platform, announced today its quarterly sales increased 70% in the quarter ending March 31, 2019. The growth reflects the revenue booked in the quarter versus the same quarter of the previous year.

Leafbuyer’s 70% year-over-year growth rate is more than double the industry’s national average of 26.7%, according to Arcview Market Research and BDS Analytics.

“Leafbuyer continues to accelerate revenue growth quarter to quarter. The results reflect our aggressive sales strategy and ongoing efforts to drive more value to our dispensary and product clients. The diversification of our revenue streams continues as we expand our loyalty platform nationwide. We plan to continue aggressively growing our client base with a constant eye for the right acquisition partners,” said Kurt Rossner, CEO of Leafbuyer.

Leafbuyer garners revenue from the sales of its sophisticated marketing technology platforms, which drive cannabis consumers to dispensaries and product companies. The solutions include texting/loyalty, mobile application-based order ahead, blockchain, and access to millions of cannabis consumers through the Leafbuyer.com website and its network partners.

“We plan to double our sales and support teams by Fall 2019 to manage the increased demand for our products and services,” said Rossner.     Read this and more news for LBUY at:    https://www.financialnewsmedia.com/news-lbuy/  

In the industry developments and happenings in the market this week include:   

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD.TO) (OTCQX: TGODF) recently announced that it has obtained approval from Health Canada, under the Cannabis Regulations, to expand operations into its new state-of-the-art building located in Hamilton, Ontario. The 20,000 square feet indoor facility is going to be used for cannabis cultivation; planting will start in the coming weeks.

“This is yet another important milestone for our team as we continue to ramp up production with a focus on executional excellence,” commented Brian Athaide, CEO of TGOD. “We have pioneered the concept of sustainably growing all-natural, certified organic cannabis at scale. The product we are able to offer Canadians is clean, pesticide-free and undeniably premium.”

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) and MediPharm Labs Corp recently announced that it has agreed to a multi-year supply deal with Cronos Group Inc.  Per the deal, MediPharm will supply Cronos Group’s wholly-owned subsidiary, Peace Naturals Project Inc., with roughly $30 million in cannabis concentrate over 18 months. These figures could jump to $60 million over 24 months, subject to certain renewal and purchase options.

Under a separate two-year tolling agreement, Cronos selected MediPharm’s Barrie, Ontario extraction facility as its preferred partner for particular processing needs. Peace Naturals will supply bulk dried cannabis to MediPharm for processing bulk resin and other cannabis derivatives which will be sold under the Cronos brand.

CV Sciences, Inc. (OTCQB: CVSI), a preeminent supplier and manufacturer of hemp cannabidiol (CBD) products, recently announced that its industry-dominating PlusCBD Oil™ products were used in the first study to date examining the clinical benefit of CBD for the treatment of Post-Traumatic Stress Disorder (PTSD).  The study, published in The Journal of Alternative and Complementary Medicine in April 2019, examined the effect of oral CBD administration on symptoms of PTSD in a series of 11 adult patients at an outpatient psychiatry clinic. CV Sciences provided various PlusCBD Oil products for the study; delivery systems and usage were determined by patient and provider preference. The published study can be viewed at the following link: Cannabidiol in the Treatment of Post-Traumatic Stress Disorder: A Case Series. CV Sciences was not involved in the data collection, data interpretation, the preparation of the article, or the decision to submit for publication.

Canopy Growth Corporation (NYSE: CGC) (TSX: WEED.TO) recently announced that it has signed an offtake agreement with PharmHouse Inc. (“PharmHouse”), a 49 per cent-owned joint venture of Canopy Rivers Inc.. Under the terms of the agreement, PharmHouse has agreed to allocate high quality cannabis flower from an additional 20 per cent of the flowering space available at its Leamington greenhouse facility over the next three years.

Boasting 1.3 million square feet of greenhouse grow space, and leveraging the resources of Canopy Growth, Canopy Rivers and its joint venture partner have worked diligently since October 2018 to prepare the facility for licensing.  PharmHouse will leverage Canopy Growth’s genetics – selected and supplied by the Company – and flower will be returned to the Company to be sold under Canopy Growth’s diverse brands and banners.  Under the terms of the new offtake agreement, PharmHouse is committed to producing GMP-certified, high quality cannabis flower within 18 months of its cultivation license and the flower must comply with the Company’s high standards for cannabis quality. GMP, or Good Manufacturing Practices, certification is the internationally recognized system to ensure all produced goods meet the highest consumer health and safety standards, allowing the Company to export the flower to its international divisions. Including this new agreement, 30 per cent of PharmHouse’s total flowering space has been committed to Canopy Growth.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM expects to be compensated twenty five, Inc. by the company.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$OGRMF Stock Consistently Holds Above The 50-Day MA

OrganiGram stock is one of the few cannabis stocks which has been consistently trading above the 50-Day Moving Average Price. OrganiGram Holdings (TSXV:OGI) (OTCQX:OGRMF) stock has been doing very well since the beginning of this year with a gain of over 80%.

The 50-day moving average is a popular technical indicator which traders use to analyze price trends. It is just a security’s average closing price over the last 50 trading sessions.

In fact, OrganiGram stock has not dropped below the 50-Day MA since early February, 2019. While other popular stocks like Aurora Cannabis (TSX:ACB)  (NYSE:ACB), Canopy Growth Corp (TSX:WEED) (NYSE:CGC), and Tilray Inc (NASDAQ:TLRY) are trading below their respective 50-Day MA.

The stock has outperformed the boarder cannabis market with a gain of over 17% since April 26, while ETFMG Alternative Harvest ETF (MJ), which tracks the broader cannabis stocks, is down 4% during the same period.

Let’s analyze the company’s recent developments.

On April 26, cannabis grower OrganiGram Holdings announced plans to move to the NASDAQ exchange indicating that they have already filed paperwork to list their stock on the exchange. On the same day, the stock went up about 12%.

OrganiGram Stock Growth | Expanding Operations

The Atlantic based cannabis grower has a grow site in Moncton, New Brunswick and they are already working on a fourth phase expansion in 2019 that once complete will ensure the company has close to 490,00 square feet of cultivation space.

Although this doesn’t look a large space the company is trying to optimize the usage of the space by stacking the grow farm to be three tiers high. Through this strategy, the company expects better yields per square foot of about 230 grams which is almost double the industry average of around 100 g per square foot. On average, OrganiGram annually produces 113,000 kg which is sufficient to guarantee a top ten spot among Canadian growers.

There is more for OrganiGram stock investors. Besides production efficiencies, the company can also take advantage of its geographical positioning. Although the eastern provinces are not as populated with consumers as in the Atlantic Provinces, they consume more marijuana than other regions. This puts OrganiGram at the top of the leader-board for Canada’s demand.

OrganiGram has also indicated they will renovate 56,000 square feet of space at Moncton campus to add their extraction capacity. The company wants to expand their product portfolio to boost their margins.

OrganiGram Financial Results

OrganiGram announced its Q2 2019 results which showed that despite the company swinging a loss it nonetheless made significant progress in derivative development, and production expansion, and improvements of the balance sheets. The company made progress in Q2 posting revenue growth of over 1,000% with net revenue including excise taxes almost doubling from Q1 when they generated $20.02 million. The bulk of sales in Q2 were from recreational use marijuana following its legalization last year.

OrganiGram managed to generate a positive EBITDA for the third consecutive quarter posting around $10 million which is 49% of its net revenue.

OrganiGram stock is up about 1% on the NYSE and trading above the 50-Day MA price of $9.03. So keep an eye on the stock because if it slips below $9 there could be some sell-off. In other words, $9 could be a solid technical support for the OGRMF stock.

$RIV $RIV.V $CNPOF Backs BioLumic

BioLumic‘s Proprietary Technology Harnesses the Power of UV Light to Sustainably Improve Crop Performance and Yield

TORONTO and PALMERSTON NORTH, New Zealand, May 15, 2019 – BioLumic Ltd. (“BioLumic”), creators of a sustainable ultraviolet (UV) crop yield enhancement system, and Canopy Rivers Inc. (“Canopy Rivers”) (TSXV: RIV), (OTC: CNPOF) today announced a strategic investment from Canopy Rivers. BioLumic extended the Finistere Ventures-led Series A financing round to include Canopy Rivers’ strategic investment of US$1.5 million, closing the oversubscribed round at US$6.7 million. The financing was comprised of a tier-one investor roster that also included Rabo Food & Agri Innovation Fund and Radicle Growth acceleration fund.

This marks Canopy Rivers’ first investment in agri-technologies, specifically focused on the promising fields of plant physiology and UV photobiology. With extensive global trials in traditional and high-value produce crops already underway, BioLumic will use the added investment to grow its team to support the acceleration and expansion of its UV light treatment initiatives, including applications in the medical cannabis market.

“Canopy Rivers’ mission is to build and support a thriving global cannabis economy, and we are dedicated to identifying and investing in strategic technology players throughout the legal cannabis value chain,” stated Mary Dimou, Director, Business Development, Canopy Rivers. “Led by an exceptional management team, BioLumic’s groundbreaking, proprietary UV technology has the potential to significantly improve cannabis growth, vigor and yield – promising an environmentally friendly, GM-free cannabis crop through the power of light.”

Already demonstrating game-changing results in produce-crop trials around the globe, BioLumic’s UV light treatments deliver long-term crop benefits such as improved crop consistency, increased yield, drought tolerance, and disease and pest resistance. With the global legal cannabis market expected to top $146 billion by the end of 2025 and increasing legalization of cannabis usage and farming around the globe, BioLumic aims to help commercial producers cultivate stronger, healthier plants to meet the rising demand for cannabis and cannabis-derived products in the regulated medical cannabis market.

“Growers need more sustainable ways to meet global crop demands, and precision UV light treatments can safely activate important characteristics in seeds and  seedlings that make them more productive as they mature,” said BioLumic CEO Warren Bebb. “Canopy Rivers’ extensive network in the cannabis industry and its ecosystem of companies will open a new, strategic market for BioLumic. Given our results with other flowering crops, the cannabis plant is a natural fit for our technology.”

Building out its data science and machine learning teams, BioLumic will use the funding to accelerate the research and commercialization of its UV light crop yield enhancement system – with a focus on developing cannabis-specific UV treatments to improve yield and increase the concentration of cannabinoids, such as cannabidiol (CBD). It will continue to focus on traditionally grown produce such as lettuce, broccoli, strawberries and tomatoes, and increase its focus on seed treatments for row crops. The company plans to explore indoor farming and protected-environment, high-value crops in the future.

Canopy Rivers is proud to collaborate with BioLumic and its leading agtech venture partners to extend BioLumic’s commercial and propriety agri-technologies for potential application in the medical cannabis sector. Finistere Ventures, focused on agtech and supported by industry leaders like Bayer and Nutrien, works closely with its extensive network in the ag and food space to help commercialize innovations at a global scale. Rabo Food & Agri Innovation Fund was launched by Rabobank, a global leader in food and agriculture financing, and invests in high-potential, early-stage food and agriculture companies.

Dr. Adrian Percy, newly appointed CTO of Finistere Ventures and the former head of R&D for the Crop Science Division of Bayer, has joined the Board as Chairman, while Finistere’s Arama Kukutai will stay on as a Board Observer. As part of the investment, Canopy Rivers’ Mary Dimou will join the BioLumic Board as an Observer. Dean Tilyard, CEO of The Factory in Palmerston North, New Zealand, will also join the Board.

“It is exciting to consider the broad range of benefits that BioLumic technology can offer to both seed producers and growers across a range of crops – from improved yield and consistency to reduction, and potentially replacement, of certain chemical and biological inputs,” noted Percy.

About BioLumic
BioLumic harnesses the power of ultraviolet (UV) light to empower growers and seed producers around the globe. Clean, green and GM-free, BioLumic’s pioneering technology activates natural mechanisms in seeds and seedlings that increase plant growth, vigor, and natural defense mechanisms — resulting in increased yields at harvest. Backed by top Ag investors, BioLumic is headquartered in New Zealand and is actively growing its presence in North America. To learn more, visit www.biolumic.com.

About Canopy Rivers
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit www.canopyrivers.com.

Forward-Looking Statements

This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Canopy Rivers with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding: BioLumic’s use of the invested funds; the application and benefits of BioLumic’s technology on cannabis and other crops; the promising fields of plant physiology and photobiology; the ability of Canopy Rivers’ network and ecosystem to open a new, strategic market for BioLumic; the size of the global legal cannabis market and global legalization of cannabis usage and farming; Canopy Rivers’ mission and strategy to identify and invest in the legal cannabis value chain; Director and Board Observer appointments; and other expectations regarding economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Canopy Rivers  believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of Canopy Rivers. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; BioLumic’s capital requirements; the use and impact of BioLumic’s technology on cannabis and other crops; developments in the fields of plant physiology and photobiology; the ability of BioLumic and Canopy Rivers to collaborate;  opportunities for investment in the legal cannabis value chain; changes in Director and/or Board Observer appointments; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in Canopy Rivers’ final short form prospectus dated February 21, 2019, filed with Canadian securities regulators and available on Canopy Rivers’ profile on SEDAR at www.sedar.com.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Canopy Rivers has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Canopy Rivers does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

$LXRP DehydraTECH Formulation Delivers 475% More CBD to Bloodstream

• The DehydraTECH formulation delivered measurable quantities of cannabidiol (“CBD”) into blood in as little as 2 minutes;
• Lexaria’s technology delivered more CBD to bloodstream in 15 minutes than conventional medium chain triglyceride (“MCT”) oil based control formulation achieved in 60 minutes;
• The area under the curve (“AUC”) for Lexaria’s patented DehydraTECH formulation was 389% more than the MCT oil control formulation;
• Lexaria’s DehydraTECH formulation delivers cannabinoids at industry-leading volumes and speed while effectively masking bitter flavor and aroma profiles.

KELOWNA, BC / May 15, 2019 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, has proven in animal testing that Lexaria’s DehydraTECH^TM technology delivers cannabinoids to the bloodstream much more quickly and effectively than conventional industry cannabinoid edible formulation designs that often combine cannabinoids with MCT oils such as coconut oil.

BACKGROUND

On March 20, 2019, Lexaria announced it had commenced a series of animal studies with multiple objectives, including gaining a better understanding of how edible forms of cannabinoids enter the bloodstream. Initial results from these studies are now available and Lexaria expects to make a series of announcements disclosing results as they are processed.

In the first animal study results announced today, Lexaria compared its standard DehydraTECH formulation that combines cannabinoids with long-chain fatty acids (“LCFA”) using Lexaria’s patented dehydration processing technique to a concentration-matched formulation utilizing coconut oil which is a commonly used medium chain triglyceride (“MCT”) oil in the cannabis edibles industry.

MCT oils are commonly used by many firms making and selling cannabis edibles throughout North America.Lexaria has consistently postulated that the use of MCT oil in edibles is less effective for purposes of cannabinoid delivery optimization than its patented DehydraTECH LCFA formulations. Although these studies tested only for CBD delivery, Lexaria has every reason to believe that virtually identical results would have been achieved if THC was instead the cannabinoid under examination, consistent with subjective human clinical studies Lexaria’s partners have conducted with edible THC products.

TEST RESULTS

In each arm of the Lexaria animal studies, 10 male Sprague-Dawley rats were administered CBD at 25mg per kg of bodyweight. Delivery of CBD into the bloodstream was monitored over a 60-minute duration. Certain data are not being disclosed at this time for reasons of intellectual property protection.

Above: Lexaria LCFA Formulation vs. MCT Formulation

• At 2 minutes DehydraTECH’s LCFA formulation delivered measurable CBD in blood, compared to no measurable CBD in blood until 6 minutes and onwards for the MCT oil formulation.
• At 15 minutes DehydraTECH’s LCFA formulation achieved a CBD blood concentration level that was 475% more than the MCT oil formulation; and, the DehydraTECH LCFA formulation CBD blood levels reached at 15 minutes were greater than the CBD blood levels reached by the MCT oil formulation at any time point during the 60-minute evaluation.
• At 60 minutes DehydraTECH’s LCFA formulation achieved a CBD blood concentration level of 319% more than the MCT oil formulation.
• Over the entire 60-minute study, the animals that received the standard DehydraTECH LCFA formulation achieved an average maximum CBD blood concentration level that was 334% more than the average maximum blood concentration level of the animals that received the MCT oil formulation (p<0.0021).
• Over the entire 60-minute study, the area under the curve (AUC) (total quantity of CBD delivered) for the Lexaria DehydraTECH LCFA formulation was 389% more than the MCT oil formulation (p<0.0011).

Lexaria also tested for brain tissue concentrations to quantify 8-hour CBD delivery from the DehydraTECH-enabled LCFA formulation compared to the MCT oil formulation and DehydraTECH’s LCFA formulation outperformed the MCT oil formulation by 246%. As was previously demonstrated through two series of animal tests delivering nicotine in 2018, Lexaria’s DehydraTECH continues to deliver a drug both to the bloodstream and across the blood-brain-barrier (“BBB”) more effectively than industry standards. More efficient delivery into bloodstream and across the BBB can lead to increased consumer satisfaction and results utilizing lower drug dosage quantities.

CONCLUSION

The cannabis edibles industry has partially embraced the use of MCT oils such as coconut oils as a co-ingredient in edible products, mostly because of the luxurious taste and mouth-feel of coconut oil. Lexaria’s head-to-head animal absorption study has proven that coconut oil formulations deliver cannabinoids into animal bloodstreams very poorly at only about one-quarter the rate of the patented Lexaria LCFA formulation. Lexaria’s DehydraTECH technology was also shown to deliver CBD considerably more quickly than MCT oil formulations.

Lexaria’s patented DehydraTECH technology has been used by licensees in the cannabis industry for three years and has been proven to effectively mask the bitter flavors and aromas of cannabis without the use of MCT oils, artificial chemical masking agents, or additional flavoring agents or sweeteners. DehydraTECH’s LCFA formulation is capable of delivering cannabinoids at industry-leading volumes and speed and simultaneously offering the most advanced flavor and aroma profile masking techniques in the industry.

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH™ delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.

www.lexariabioscience.com

For regular updates, connect with Lexaria on Twitter https://twitter.com/lexariacorp and on Facebook https://www.facebook.com/lexariabioscience/.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.
Alex Blanchard, Communications Manager
(250)765-6424 Ext 202
or
NetworkNewsWire (NNW)
www.NetworkNewsWire.com

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional stock warrants or stock options will be exercised. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements; or that results from any studies will be favorable or in any way support future business activities of any kind. Scientific R&D is often unpredictable and unanticipated results could emerge from any study and have a material impact. There is no assurance that positive results from animal testing will be reproduced nor that similar positive results will be apparent in human tests of a similar nature. There is no assurance that any planned corporate activity, scientific study, R&D, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). TurboCBD^TM, DehydraTECH^TM technology and ViPova^TM products are not intended to diagnose, treat, cure or prevent any disease.

$NUGS Approved to Uplist to OTCQB Venture Market

LOS ANGELES, May 15, 2019 — via NetworkWire — Los Angeles-based Cannabis Strategic Ventures Inc. (OTC: NUGS) announces it is approved for trading on the OTCQB Venture Market, effective May 10, 2019. Uplisting is important for the Company as it continues to build shareholder value through more stringent reporting standards and increased investor transparency.

“Uplisting Cannabis Strategic Ventures’ stock to the OTCQB Venture Market is an exciting milestone for our Company,” said Simon Yu, CEO of Cannabis Strategic Ventures. “The OTCQB platform will allow us to provide investors increased transparency by providing the information needed to analyze, value and trade.”

This achievement is the latest development in Cannabis Strategic Ventures’ expansion plans. The Company, which owns several brands in the cannabis and hemp-derived cannabidiol (“CBD”) sectors, recently announced the cultivation of land for over 20,000 plants at NUGS Farm North, its 6-acre licensed site in Northern California. The farm is expected to operate at maximum capacity by late summer of 2019. In addition, Cannabis Strategic Ventures recently announced its investment in FLORAH, a concept boutique that educates consumers of the benefits of CBD while a curating a best of selection of CBD lifestyle, wellness, beauty and pet products.

“The benefits of uplisting combined with our new initiatives demonstrate to our existing investors and the marketplace that Cannabis Strategic Ventures is on track for growth,” stated Yu. “We have a clearly defined path for expansion and we are diligently working to meet our corporate goals.”

About Cannabis Strategic Ventures
Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS.

FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance.

Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

Contact:
Arlene Guzman
Phone:+1-310-359-6860
Email: IR@CannabisStrategic.com
Website: http://www.CannabisStrategic.com

Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

$TGODF $TGOD Releases Q1 Fiscal 2019 Financial and Operational Results

$TCAN Executes LOI to Acquire Award-Winning Cannabis Brand SolDaze

VANCOUVER, British Columbia, May 15, 2019 — via NetworkWire – Transcanna Holdings Inc. (CSE:TCAN: XETR: TH8) (“TransCanna” or the “Company”) is pleased to announce today the execution of a non-binding Letter of Intent dated May 15, 2019 (“LOI”) with Tres Ojos Naturals, LLC d/b/a SolDaze (“SolDaze”), a limited liability company from Santa Cruz, California, to acquire the branding asset package, Soldaze (the “Assets”). SolDaze produces cannabis-infused fruit snacks in California.  For more information on SolDaze product lines, please see their website: www.soldazesnacks.com.

“Having reviewed over 100 branded products in California, we’ve been extremely selective in our acquisition vetting process. Our three mandatory acquisition criteria include SKU velocity, upward trending revenues, and products that differentiate themselves in the marketplace.  The snack line from SolDaze, and specifically the cannabis-infused mango products, meets all three requirements,” stated Jim Pakulis, CEO of TransCanna.

“Over the past year, we’ve created a unique line of fruit-based, organic edibles that truly differentiate us in the market. We then began supplying select dispensaries and almost immediately began receiving repeat orders. We’re now at the stage where we need to expand throughout California,” stated Shawn Shevlin, founder and president of SolDaze. “ TransCanna’s platform, including the 196,000-square-foot facility; their commitment to supplying the necessary capital for our immediate growth; and their adherence to compliance will provide SolDaze the tools and guidance that are mandatory in order to be successful and scale in California.”

Pursuant to the LOI, the Company would acquire the Assets for a cash payment of USD$350,000 and the issuance of 660,000 common shares in the capital of the Company. A nonrefundable deposit of US$50,000 was paid on the execution of the LOI, to be credited against the purchase price. The purchase price is payable in installments over a two-year period, provided that the timing of such installments may be accelerated should the sales of SolDaze products meet specific revenue targets, and the number of shares issuable may be reduced by up to 37,125 in the event that the revenue targets specified are not met by the dates specified.

The completion of the Asset acquisition remains subject to completion of due diligence and execution of final binding definitive asset purchase documentation, which is to be completed within 45 days of the date of the LOI. There can be no assurances that the completion of the acquisition will occur on the terms set forth above or at all.

For further information, please visit the Company’s website at www.transcanna.com.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly owned California subsidiaries, to a range of industries including the cannabis marketplace.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.

Media Contact
TransCanna@talkshopmedia.com
604-738-2220

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer

Telephone: (604) 609-6199

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

$NUGS Expands Portfolio in California’s Cannabis Space

• Cannabis Strategic Ventures is dedicated to supporting entrepreneurial growth in California’s cannabis industry through acquisitions and partnerships
• California’s cannabis industry is the world’s largest market for the plant’s products, with expected sales revenues of $7.7 billion by 2022
• NUGS subsidiary Asher House gained prominent media attention this month after an appearance on the Ellen DeGeneres show

California’s pioneering entry into the medical cannabis and recreational marijuana industries continues to attract challenges, as exemplified through recent concerns over an expected supply shortage when some 10,000 cultivators’ temporary state licenses expired at the end of April (http://nnw.fm/cInx4).

As California’s legal infrastructure struggles to find a solution to keep businesses operating legally and to stave off costly lawsuits, companies such as Los Angeles-based Cannabis Strategic Ventures Inc. (OTC: NUGS) that have placed a priority on holding licenses that keep them in the state’s good graces are positioned to weather the regulatory storms with a corporate calm that allows them to focus all of their efforts on core mission fundamentals.

NUGS’ year began with announcements that it would partner with a Santa Barbara County cultivator that holds about 40 commercial cannabis licenses (http://nnw.fm/XUAd5) and that NUGS has also garnered over 20 licenses for cannabis cultivation, manufacturing and distribution, allowing it to proceed with breaking ground on a six-acre Northern California canopy cultivation site known as The NUGS Farm (http://nnw.fm/UE0oT), establishing a presence for the company at both ends of the state.

“Establishing The NUGS Farm and securing these licenses are significant milestones for Cannabis Strategic Ventures,” CEO Simon Yu stated in a news release. “We are proud of what we have accomplished at this stage of the company. As the cannabis industry expands, and as we work to make cannabis legal on a federal level, Cannabis Strategic Ventures will be in position to touch on all areas of cannabis production.”

Cannabis Strategic Ventures is focused on supporting entrepreneurial growth within the legal cannabis sector, which has gained an explosive degree of popularity and social awareness in North America during recent years. The company is building a portfolio of varied subsidiaries and, in February, gained a boost to that end from an investment of up to $3 million from a university student initiative known as Triton Funds, announced as effective once an upcoming S1 registration statement is completed.

One company subsidiary benefitted in April from significant media attention after Luke Barton and Lee Asher of the Asher House shelter dog adoption enterprise appeared on the Ellen DeGeneres show and were honored for their efforts to help pets find homes, receiving a $10,000 check from DeGeneres’ ally, ShutterFly Inc. (http://nnw.fm/2qCFP), as well as news coverage following the appearance (http://nnw.fm/2yCUI). Asher House joined the Cannabis Strategic Ventures team last year when NUGS acquired a controlling interest in Asher House’s Pet CBD line of hemp-derived cannabidiol supplements (http://nnw.fm/TrYo0).

California remains the world’s largest cannabis market, and researchers at BDS Analytics forecast that sales of cannabis will hit $5.1 billion this year in the state (http://nnw.fm/vFc3R). Continuing this trend, Cannabis Business Plan analysts predict that the state industry will reach $7.7 billion in annual revenues by 2022 (http://nnw.fm/mf6SE).

For more information, visit the company’s website at www.CannabisStrategic.com

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://nnw.fm/NUGS

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$VVCIF Rosy Forecast for Booming Multi-Billion Dollar Hemp Industry

Palm Beach, FL – May 14, 2019 – A couple of recent articles painted a rosy picture for hemp cultivation in the next few years. An article on Marijuana Moment said: “Industrial hemp production significantly increased in the U.S. in 2018, with farmers cultivating three times as many acres of the crop as compared to the previous year… Farmers grew more than 78,000 acres of legal hemp last year, the advocacy group VoteHemp reported. In 2017, they grew about 26,000 acres and in 2016, the total was just under 10,000 acres… But while those are impressive gains—the product of a growing number of state-level reform policies that expanded the pool of farmers licensed to grow hemp… expect another massive surge in 2019 thanks to hemp’s outright legalization through the new Farm Bill… The legislation is a game-changer in terms of production estimates, advocates say.  And it’s not just California and Colorado and the western states that are getting into the picture. An article focusing on northeastern U.S said: “Other owners of tens of thousands of acres of preserved agricultural land are betting on a bill that’s working its way through the state Legislature that will allow them to join a business that’s expected to be worth $22 billion by 2022… The demand for CBD products is exploding. At the moment the demand is far outpacing the supply,” said Heather Darby, a hemp expert at the University of Vermont Extension who has advised agricultural officials and prospective hemp cultivators in Massachusetts. “Farmers and businesses are scaling up production quickly and moving from producing an acre to producing 50 acres… About 1,500 to 2,000 hemp plants can be grown per acre generating between $40,000 and $50,000, according to information provided by Brightfield Group, a Chicago-based cannabis research firm.     Active Companies from around the market with current developments this week include:  Marijuana Company of America, Inc. (OTC:MCOA), VIVO Cannabis Inc. (TSX-V: VIVO) (OTC: VVCIF), MariMed Inc. (OTC: MRMD), Kona Gold Solutions, Inc. (OTC: KGKG), Terra Tech Corp. (OTC: TRTC).

“It’s hard to say what’s going to happen. Right now, it’s an open market. People are trying to work as fast as possible to meet that high demand,” said an industry exert. “People think there’s a lot of money to be made … big profits. That may be true, but you have to have a crop to be able to obtain a profit.”  The Marijuana Moment article concluded: ““Sales of hemp products have been growing at a double digit pace for several years and demand for CBD has been phenomenal… Now that hemp has been removed from the Controlled Substances Act, we expect demand for American hemp to continue to increase and project that at least 125,000 acres of hemp will be planted nationally in 2019…. the end of hemp prohibition means “it’s time to invest our energy in expanding hemp cultivation and the market for hemp products across the country so that all can reap the benefits of this versatile, historic American crop.”

Marijuana Company of America, Inc. (OTCQB:MCOA) BREAKING NEWS:  Marijuana Company of America, an innovative hemp and cannabis corporation, announced today that the Company has signed a Letter of Intent (“LOI”) with Essence Farms, LLC, (“Essence”) to form a joint venture (“JV”) called Riverside Hemp Project to run farming operations in California for the purpose of growing, cultivating, manufacturing, extracting and selling legal hemp and hemp-derived CBD.

Through the agreement, Marijuana Company of America will provide hemp seeds, genetics, management of operations and standard operating procedures. Essence, a cultivator and land owner, will provide all necessary licenses for the legally compliant growth and sale of hemp in Riverside, California.

“MCOA strives to be a leader in producing and distributing hemp, and we believe this joint venture will allow the Company to further its vision by establishing itself as a premier company in the hemp sector,” said Don Steinberg, Chief Executive Officer of Marijuana Company of America. “With the ongoing return of net profits this project is expected to provide MCOA, we are confident that signing this Letter of Intent is another strategic step for the Company and we look forward to expanding further in both the cannabis and hemp markets in California. If all goes according to plan, this will by far be the most financially successful venture the Company has been involved in.”

Marijuana Company of America will receive an 80% return of net profits for the JV on an ongoing basis, as well as a long-term lease on the property with favorable lease terms. The project includes up to 500 usable acres of land in California’s Riverside County that has sufficient water and power and is specifically suited for large-scale cultivation. The Company is in the process of sourcing the highest quality seeds that will yield a high percentage of CBD with legally compliant low levels of THC. It is projected that each acre will produce 2,500 pounds of hemp biomass. Based on prevailing fair market rates at this time, the biomass can be sold for approximately $35 a pound. If the Company processes the biomass as it intends to do, at least in part, the biomass will produce a significantly higher financial return. Additionally, the property is equipped with several large structures that are suitable for the storage and drying of the hemp plants. A highly experienced cultivation team has been engaged to manage the operations and cultivation of the farm.    Read this and more news for MCOA at:  https://www.financialnewsmedia.com/news-mcoa/  

In the industry developments and happenings in the market this week include:   

VIVO Cannabis Inc. (TSX-V: VIVO) (OTCQX: VVCIF) recently announced that its wholly-owned subsidiary, Canna Farms Limited (“Canna Farms”), has completed registration with Alberta Gaming, Liquor & Cannabis (“AGLC”) to supply the Province of Alberta with its well-recognized premium cannabis products. Canna Farms is preparing its first shipments for immediate delivery to AGLC.

“We are very excited to bring our premium products to the Alberta consumer market, one of the strongest in Canada , and fill some of the current industry supply gaps while continuing to expand our distribution channels,” said Daniel Laflamme , President of Canna Farms. “Following Health Canada’s approval of our facility expansion, allowing us to double our current production capacity, we are eager to expand our customer base in Alberta , where the Canna Farms brand is well-known, and look forward to shipping to all Canadian provinces and territories in 2019 in connection with our production ramp-up.”

“To facilitate efficient shipping, we have invested in automated packaging and labelling equipment to address some of the downstream challenges faced by producers in getting their products to market,” added Brian McDonald , Vice-President of Canna Farms. “We are also actively working on developing different concentrates and edible products, and using automation to expedite the production process. Having Alberta as a long-term partner, and continuing to invest in premium quality indoor production, will help us to continue to differentiate Canna Farms as a true premium cannabis company and a market leader in quality and reliable supply.”

MariMed Inc. (OTCQB: MRMD) one of the largest multi-state cannabis operators in the US, recently announced 2019 first quarter results for the period ending March 31, 2019. Continued Strong Revenue Growth and Improved Operating Performance – In the first quarter ended March 31, 2019, revenues grew 69% to $3.5 million, compared to $2.1 million for the first quarter of 2018.  Gross profit grew 90% to $2.2 million vs. $1.2 million for the first quarter of 2018 compared to the same period in 2018. Gross profit as a percentage of revenue grew from 57% in the first quarter of 2018 to 64% in the first quarter of 2019. Both the improvement in revenue and gross profit percentage reflect the strong performance of the underlying operations under the Company’s management. Adjusted EBITDA grew 76% to $585,000 compared to $332,000 in the same period in 2018.

Financial Strength–MariMed’s balance sheet continued to strengthen during the first quarter. Total assets, grew 17.6% during the quarter to $97.6 million, compared to $83.0 million at December 31, 2018. To help fund growth initiatives, the company raised $8.37 million in financing activities during the quarter, principally from sales of common stock and promissory notes.

Kona Gold Solutions, Inc. (OTCPK: KGKG), a hemp and CBD lifestyle brand focused on product development in the functional beverage sector, recently announced the sponsorship of World Ranked #1 professional skier, Ryan Dodd.  Ryan Dodd has signed a two-year agreement with Kona Gold where he will represent the brand’s Kona Gold Hemp Energy Drinks on a global level as he travels and competes in events around the world.

“Kona Gold is a leader and innovator in the functional beverage industry. We found it fitting to join forces and continue to raise the bar together setting the Gold Standard. I’m so excited for the future with this premier lifestyle brand,” stated Ryan Dodd.

Terra Tech Corp. (OTCQX: TRTC), a vertically integrated cannabis-focused agriculture company, recently announced its financial results for the period ended March 31, 2019.

Derek Peterson, Chief Executive Officer of Terra Tech, commented, “In the first quarter of 2019 we made meaningful headway both implementing our restructuring strategy and further entrenching ourselves in the California market. All material construction at the Hegenberger cultivation facility in Oakland is complete, and we anticipate it being fully operational upon receipt of licensing approval from the State. This will enable us to ramp production of our IVXX™ premium wholesale cannabis brand in California.”

“We also opened our newest Blüm dispensary in San Leandro, California, a prominent suburb city of San Francisco and Oakland. In the short time since opening, the dispensary has generated consistent medical foot traffic and we expect sales at this location to continue to grow throughout the year, driven by the start of sales to adult users as of May 2019, and increased brand recognition in the area. Moreover, we are working on several growth initiatives that are expected to generate new sources of revenue for the Company, including opening a vertically integrated cannabis complex to host large-scale, cannabis themed events at our East Dyer Road location later this year,” continued Mr. Peterson.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM expects to be compensated forty six hundred dollars for news coverage of the current press release issued by Marijuana Company of America, Inc. by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:

Media Contact email: editor@financialnewsmedia.com – +1(561)325-8757

$TGODF $TGOD Approval to Start Cultivation at New Hamilton Building

TORONTO, May 14, 2019  – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce that it has obtained approval from Health Canada, under the Cannabis Regulations, to expand operations into its new state-of-the-art building located in Hamilton, Ontario. The 20,000 square feet indoor facility is going to be used for cannabis cultivation; planting will start in the coming weeks.

“This is yet another important milestone for our team as we continue to ramp up production with a focus on executional excellence,” commented Brian Athaide, CEO of TGOD. “We have pioneered the concept of sustainably growing all-natural, certified organic cannabis at scale. The product we are able to offer Canadians is clean, pesticide-free and undeniably premium.”

The newly built facility is the second of three buildings at TGOD’s Hamilton site, which will have a total size of 166,000 square feet when all are completed later this summer, and an annual production capacity of 17,500 kgs.

The Company is also seeking an eGMP certification for this facility in order to allow for global exports, as laws and regulations permit.

On Behalf of the Board of Directors,

The Green Organic Dutchman Holdings Ltd.

About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US: TGODF) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD also has organic hemp CBD oil operations in Canada, and through its wholly owned subsidiary HemPoland distributes premium hemp CBD oil in the EU. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about future facility construction, statements about future production capacity, statements about the achievement of certain certifications in connection with its facilities, statements about the receipt of any regulatory permits or licences, statements about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.